Al-Ali, HK; le Coutre, P; Duyster, J; Linkesch, W; Wolf, D; Schanz, U; Baerlocher, GM; Wackwitz, B; Heim, D.
ENACT (Expanding Nilotinib Access in Clinical Trials) study in adult patients (pts) with Imatinib-resistant or -intolerant Chronic Myeloid Leukemia (CML): Subgroup analysis of Pts from Germany, Austria and Switzerland (DACH)
Onkologie. 2011; 34(6):267-267.-Jahrestagung der DÖuSGHO; SEP 30-OCT 04, 2011; Basel.
[Poster]
Web of Science